Crinetics Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an…

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Crinetics Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Crinetics Pharmaceuticals, Inc. can't present revenue by segment

End of CRNX's Analysis
CIK: 1658247 CUSIP: 22663K107 ISIN: US22663K1079 LEI: - UEI: -
Secondary Listings
CRNX has no secondary listings inside our databases.